ITI Pharma and Healthcare Fund · Regular · Growth
NAV
₹18.6207
as of 13 Nov 2026
Expense Ratio
2.57%
AUM
₹266 Cr
Lumpsum returns (CAGR)
- 1Y
- +14.74%
- 3Y
- +18.32%
- 5Y
- +13.19%
- Since Inception
- +13.20%
SIP returns (XIRR)
- 1Y
- +26.13%
- 3Y
- +13.36%
- 5Y
- +16.35%
- Since Inception
- +16.35%
What history actually did — last 5 years (Nov 2021 – Nov 2026)
A ₹5,000 monthly SIP for the last 5 years (Nov 2021 – Nov 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹4,47,031 today — ₹3,00,000 invested, 16.4% XIRR.
₹3,00,000
Invested
₹4,47,031
Value today
16.4%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 5 years (Nov 2021 – Nov 2026)
Real NAV backtest
₹1,00,000 invested 5 years ago would be ₹1,85,804 today (13.2% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Nov 2021 would still hold ₹14,11,007.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹4,47,031 in this fund vs ₹3,87,935 in the benchmark — outperformance of ₹59,096.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 5 years (Nov 2021 – Nov 2026) (4 Jun 2024) would be ₹1,42,809 today (1.43×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.38
Sharpe Ratio
+0.07
Alpha
0.66
Beta
0.39
Sortino
13.16%
Std Dev
-14.24%
Max Drawdown
Performance Comparison
Related reading
Thinking about ITI Pharma and Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
What this fund does
ITI Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
ITI Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by ITI Mutual Fund. The fund has been operational for over 5 years. It manages assets worth ₹266 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 2.57%.